Rethinking the future with evolving technology: It’s time to empower change in heart transplantation

Rethinking the future with evolving technology: It’s time to empower change in heart transplantation

The authors evaluate the utility of surveillance endomyocardial biopsy performed beyond 6 months after transplantation in the modern heart transplantation era. See Oh et al. on page 825.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of transplantation 2021-02, Vol.21 (2), p.453-455
Hauptverfasser: Guerrero‐Miranda, Cesar Y., Hall, Shelley A.
Format: Artikel
Sprache:eng
Schlagworte:
alloantibody
Biopsy
Clinical outcomes
clinical research/practice
editorial/personal viewpoint
Graft Rejection
heart (allograft) function/dysfunction
Heart Transplantation
heart transplantation/cardiology
Heart transplants
immunosuppression/immune modulation
Life Sciences & Biomedicine
Medical technology
microarray/gene array
molecular biology
molecular biology: DNA
rejection
Science & Technology
Surgery
Transplantation
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The authors evaluate the utility of surveillance endomyocardial biopsy performed beyond 6 months after transplantation in the modern heart transplantation era. See Oh et al. on page 825.
ISSN:1600-6135
1600-6143
DOI:10.1111/ajt.16221